Sagimet Biosciences (NASDAQ:SGMT – Get Free Report)‘s stock had its “buy” rating reiterated by equities research analysts at HC Wainwright in a research note issued on Tuesday,Benzinga reports. They currently have a $29.00 price objective on the stock. HC Wainwright’s price target would suggest a potential upside of 181.96% from the company’s current price. A […]

AnaptysBio (NASDAQ:ANAB – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a report released on Monday,Benzinga reports. They presently have a $95.00 target price on the biotechnology company’s stock. HC Wainwright’s price target would suggest a potential upside of 66.73% from the stock’s current price. Other equities […]

Bright Minds Biosciences (NASDAQ:DRUG – Get Free Report)‘s stock had its “buy” rating reissued by equities research analysts at HC Wainwright in a research report issued to clients and investors on Wednesday,Benzinga reports. They presently have a $145.00 price target on the stock. HC Wainwright’s price target suggests a potential upside of 71.03% from the […]

Assembly Biosciences (NASDAQ:ASMB – Get Free Report)‘s stock had its “buy” rating reissued by HC Wainwright in a note issued to investors on Tuesday, MarketBeat reports. They presently have a $50.00 price target on the biopharmaceutical company’s stock. HC Wainwright’s price objective suggests a potential upside of 66.61% from the company’s current price. Other analysts […]

Avidity Biosciences (NASDAQ:RNA – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in a report released on Friday,Benzinga reports. They presently have a $25.00 price objective on the biotechnology company’s stock. HC Wainwright’s target price would indicate a potential upside of 95.31% from the stock’s previous close. RNA […]